{
    "laboratory_examinations": [
        {
            "procedure_name": "Plasma Aldosterone",
            "date": "Not specified",
            "findings": "Plasma aldosterone was 24 ng/dL and suppressed PRA (0.6 ng/mL/h) during treatment with ACE-I.",
            "changes_over_time": "Postoperatively, plasma aldosterone levels decreased, but 14 months after surgery (May 2010), plasma aldosterone increased and PRA remained suppressed."
        },
        {
            "procedure_name": "CYP11B2 gene expression",
            "date": "Not specified",
            "findings": "An increased expression of CYP11B2 was observed in HAC15 adrenal cells overexpressing KCNJ5Y152C compared to the wild-type channel, showing a 4-fold increase.",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Renal function tests",
            "date": "Not specified",
            "findings": "The patient had reduced renal function, which progressed to end-stage renal disease (ESRD).",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Hormonal testing",
            "date": "Not specified",
            "findings": "Normal catecholamine levels and normal results from dexamethasone suppression tests were reported.",
            "changes_over_time": "Not specified."
        }
    ]
}